News: Globus Medical Inc. Class A (GMED) Soars 5.69% on January 11
Globus Medical Inc. Class A (GMED) had a good day on the market for Wednesday January 11 as shares jumped 5.69% to close at $26.76. About 2 million shares traded hands on 14,068 trades for the day, compared with an average daily volume of 1.02 million shares out of a total float of 95.83 million. After opening the trading day at $25.75, shares of Globus Medical Inc. Class A stayed within a range of $27.00 to $25.66.
With today's gains, Globus Medical Inc. Class A now has a market cap of $2.56 billion.
The stock has a P/E Ratio of 20.3. Shares of Globus Medical Inc. Class A have been trading within a range of $26.46 and $19.25 over the last year, and it had a 50-day SMA of $22.95 and a 200-day SMA of $23.46.
Globus Medical Inc is a medical device company focused on developing products that promote healing in patients with musculoskeletal disorders. The Company also develops a robotic surgical navigation device and products to treat patients.
Globus Medical Inc. Class A is based out of Audubon, PA and has some 1,200 employees. Its CEO is David C. Paul.
Globus Medical Inc. Class A is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
To get more information on Globus Medical Inc. Class A and to follow the company’s latest updates, you can visit the company’s profile page here: GMED’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.